News

Enanta Pharmaceuticals Announces Respiratory Syncytial Virus Data Presentation at ESCMID Global 2025
(NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology ...
Pharmabiz4d
Theriva Biologics presents data from phase 1b/2a trial of ribaxamase in allogeneic hematopoietic cell transplant recipients
Rockville, Maryland Saturday, April 12, 2025, 18:00 Hrs [IST] ...
Morningstar8d
Enanta Pharmaceuticals Announces Respiratory Syncytial Virus Data Presentation at ESCMID Global 2025
The oral ePoster presentation will include results from a Phase 2a human challenge study of EDP-323, a first-in-class, oral, non-nucleoside small-molecule inhibitor of the RSV polymerase (L ...